See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356576_2018_Supernus_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001356576, Supernus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 228,451,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 36,019,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,124,000 |
| 3 | remainder_Assets | 154,870,000 |
| 4 | LiabilitiesCurrent | 123,000,000 |
| 5 | LiabilitiesNoncurrent | 10,577,000 |
| 6 | remainder_Liabilities | 23,407,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 279,645,069 |
| 9 | ResearchAndDevelopmentExpense | 50,290,017 |
| 10 | remainder_Expenses | -28,810,670 |
| 11 | remainder_Revenues | 441,887,558 |
| 12 | remainder_NetIncome | -313,353 |
| 13 | remainder_ComprehensiveNetIncome | 352,755 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 424,464,000 |
| 1 | Liabilities | 156,984,000 |
| 2 | Expenses | 301,124,416 |
| 3 | Revenues | 441,887,558 |
| 4 | StockholdersEquity | 267,480,000 |
| 5 | NetIncome | 140,449,789 |
| 6 | ComprehensiveNetIncome | 140,626,166 |
| 7 | BaseVar | 662,563,041 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.49 |
| 9 | EconomicCapitalRatio | 3.35 |
Edgar->Model Mapping
Feature Distribution
Change over Time
